We characterized CD34 + cells purified from bone marrow (BM), mobilized peripheral blood (PB) and cord blood (CB) and we tried to establish correlations between the cell cycle kinetics of the CD34 + CD38 − and CD34 + CD38 + subpopulations, their sensitivity to SCF and IL-3 and their expression of receptors for these two 
Umbilical cord blood (CB), mobilized peripheral blood (PB) and bone marrow (BM) are currently used as sources of hematopoietic stem cells. 1, 2 However, several phenotypic and functional differences between hematopoietic stem cells from these three tissues have been described during the last few years. [3] [4] [5] [6] The CD34
+ CD38 − phenotype corresponds to a primitive subpopulation of progenitor cells in BM as well as in CB and in mobilized PB, that can be distinguished functionally from the CD34 + CD38 + population by several in vitro assays. 7 Although for the three sources, the CD34 + CD38
− phenotype is consistent in defining the most primitive progenitors, 8, 9 functional differences between CD34 + CD38 − cells from the three tissues have been described. CD34 + CD38 − cord blood cells have a higher cloning efficiency, proliferate more rapidly in response to cytokine stimulation and generate more progenitors than their counterpart in bone marrow. 10 In this study, we characterized CD34 + cells purified from the three sources by comparing their cell cycle status and their capacity to form blast colonies in contact with BM stroma. Moreover, we evaluated the expression of receptors to SCF (CD117) and IL-3 (CD123) on the cell surface of each subpopulation at day 0 and 48 h after stimulation by SCF + IL-3. The rationale for utilizing this cytokine combination is its ability to promote in vitro expansion of CB CD34 + and CD34 + CD38 − cells. 11 The aims of our study were to establish relations between the cell cycle kinetic of CD34 + subpopulations, their sensitivity to colony-stimulating factors and their expression of SCF and IL-3 receptors.
Materials and methods

Cells
Umbilical cord blood cells were collected after full-term deliveries. Immediately after delivery, the cord was clamped, the umbilical vein was catheterized aseptically and the sample collected by gravity into a 400 ml blood unit pack containing 35 ml citrate-phosphate-dextrose adenine-1 solution (CPD-A) (Baxter Fenwal, La Châtre, France).
Bone marrow cells were obtained by aspiration from the sternum of normal donors. The samples were anticoagu-lated with 10 IU/ml heparin (Rhône-Poulenc Rorer, Brussels, Belgium).
Peripheral blood cells were obtained after cytapheresis of normal donors mobilized by 10 g/kg of G-CSF (Neupogen, Amgen, Thousand Oaks, CA, USA).
Informed consent was obtained from normal donors before any sample collection.
CD34 positive cell selection on Midimacs immunomagnetic selection systems (Miltenyi Biotec, Bergisch Gladbach, Germany)
According to the manufacturer's instructions, 50 to 200 × 10 6 mononuclear cells suspended in buffer containing PBS and 0.5% bovine serum albumin (BSA), were incubated for 15 min at 4°C with a blocking reagent (human IgG) and simultaneously with anti-human CD34 antibody (QBEND10). After washing, the cells were incubated for 15 min at 4°C with superparamagnetic MACS microbeads recognizing QBEND10. The cells were then washed and loaded on to a high gradient magnetic separation column (LS + column) washed with 3 ml buffer. The unlabelled cells were washed five times through the column using 3 ml buffer. After removing the column from the magnetic separation unit, the labelled cells are collected by washing LS + column with 5 ml buffer. Selected cells are washed once in PBS before use.
Suspension culture
CD34
+ cells are plated in 24 well plates at 10 4 to 10 5 cells/ml in serum-free medium (CellGRO, BioWhittaker, Walkersville, MD, USA) with SCF (10 ng/ml) and IL-3 (20 ng/ml). Cells were maintained at 37°C under 5% CO 2 in 100% humidity for 2 days. Viable cell number, phenotype and cell-cycle status analysis were performed at day 0 and after 2 days of culture. 
Phenotype analysis
Blast-colony forming cell assay (Bl-CFC)
This assay is dependent on the ability of the stem cell population to recognize and attach to a preformed marrow derived stromal layer and to grow in this environment without addition of exogenous growth factors. The feeder layer is obtained by culturing during 4 to 6 weeks bone marrow mononucleated cells in the presence of methylprednisolone and is composed of fibroblasts, macrophages and fat cells.
Stromal layers were prepared by plating 5 × 10 5 bone marrow mononuclear cells in 1 ml ␣-MEM (Gibco) containing 20% FCS supplemented with 2 × 10 −5 methylprednisolone (Solumedrol) (Upjohn, Kalamazoo, MI, USA) in 35-mm Petri dishes. The stromal cultures were fed weekly by complete replacement of the culture medium. After 4 to 6 weeks, stromal layers are confluent.
At this time, 1 × 10 4 cells from the starting CD34 + cell suspension and from cells recovered after 48-h culture were incubated for 2 h at 37°C and 5% CO 2 on confluent marrow-derived stromal layers to allow adherence to the stroma. The stromal layers were then washed three times with alpha-MEM to remove all cells which had not adhered. The cultures were then overlaid with 1 ml of 0.3% agar in alpha-MEM supplemented with 20% FCS and were incubated for 7 days at 37°C and 5% CO 2 . All colonies closely associated to the stromal layer and containing more than 20 cells were counted. 12 
Statistical analysis
The comparisons between either phenotype or cell cycle status at day 0 and after 48-h culture or between phenotypes of CD38 − and CD38 + populations, in the same type of sample, are performed using the Student's paired t-test. Comparisons between phenotype from different types of sample are performed using the Student's t-test.
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85.9 ± 2.9 54.3 ± 3.3 89.5 ± 1.6 61.9 ± 5.3 BM (n = 5) 96.6 ± 0.8 29.7 ± 8.3 93.9 ± 2.7 32.5 ± 3.3 PB (n = 6) 87.9 ± 5.9 43.1 ± 7.9 93.5 ± 3.0 38.6 ± 14.4
Results
CD34CD38 expression of selected cells at day 0 and after 2 day stimulation by SCF + IL-3
As shown in Table 1 , the purity of CD34 + cells, obtained using the Midimacs system, was greater than 85%. However, to exclude contamination by CD34
− cells, the phenotypes of the progenitor cells were studied by dual color fluorescence, and also by triple color fluorescence, analysis after gating on the CD34 positive cell fraction. After 2 days of culture, the number of cells remains constant for the three sources of hematopoietic stem cells evaluated, the expression of CD34 and CD38 antigens is not radically modified.
Cell cycle status of CD34 + cells from CB, BM and mobilized PB at day 0 and after 48-h stimulation by SCF + IL-3
In the first set of experiments, the cell cycle status of CD34 + CD38 − and CD34 + CD38 + cells is evaluated by flow cytometry. As shown in Table 2 , cycle analysis of the two subpopulations indicates that at day 0, the large majority of the whole CD34 + cell population from CB as from BM and mobilized PB were in G0/G1 phases of the cell cycle. Our data suggest that the CD34 + CD38 − cells from BM analyzed at day 0 are more actively cycling than their PB and CB counterpart, however after 48-h incubation with SCF + IL-3 this percentage does not increase.
Clonogenic capacities of cells before and 48 h after stimulation with SCF + IL-3
To support our observations that CB and PB CD34 + CD38
− cells are more proliferative after stimulation using SCF + IL-3 than at day 0, we have plated these cells in a culture system allowing the growth of stroma-dependent progenitors (Bl-CFC). These cells are mainly present in the CD34 + CD38 − fraction 13 and we can thus expect that this assay reflects primarily the clonogenic capacities of the CD34 + CD38 − fraction. For CB and PBSC, we have obtained respectively 5.2 ± 1 (P Ͻ 0.0009) (n = 5) and 6.1 ± 1.2 (P Ͻ 0.022) (n = 4) fold more Bl-CFC with CD34
+ cells stimulated during 48 h by SCF + IL-3 than using fresh CD34 + selected cells. For BM, the number of Bl-CFC was not significantly different before and after incubation with CSFs (n = 5). These results confirm the increased proliferative capacities of immature PB and CB CD34
+ CD38 − cells after incubation with SCF + IL-3 while BM immature progenitors maintain similar capacities.
CD117 expression on CD34
+ subpopulations from CB, BM and mobilized PB at day 0 and after 48-h culture The fact that CB and mobilized PB CD34 + CD38 − cells seem to be more responsive to SCF and IL-3 than their BM counterpart, suggesting different sensitivity of progenitors to these growth factors, may result from different receptor expression on the cell surface. Therefore, we examined the expression of SCF and IL-3 receptors on CD34 + CD38 + and CD34 + CD38 − cells purified from CB, BM and PB. This expression is evaluated in terms of receptor density (MESF) (Figure 1 ) and of percentage of positive cells (Table 3) . Due to the relatively high purity of CD34 + cells obtained using the Midimacs separation system, the results observed after two or triple fluorescence analysis were not different and were thus pooled. When we compared the density of receptors on the cell surface (Figure 1 ), CD117 expression is significantly lower on CD34 +
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− cells than on CD34 + CD38 + cells, in CB (P Ͻ 0.0004) as well as in PB (P Ͻ 0.011) and in BM (P Ͻ 0.02). This difference between the two subsets remains significant after 48-h culture (respectively P Ͻ 0.0001, P Ͻ 0.05 and P Ͻ 0.01 for CB, PB and BM). On the other hand, it is clear that at day 0, on the immature CD34 + CD38 − population, CD117 expression is significantly lower on mobilized PB cells than on their CB (P Ͻ 0.001) and BM (P Ͻ 0.001) counterparts. When the 
CD34
+ cells are incubated for 48 h with SCF + IL-3, the CD117 expression on total CD34
+ cells increases in CB and PB while it decreases in BM. This effect is probably due to the increase of CD117 expression on CD34 + CD38 + cells from CB and PB and the decrease on BM cells. Surprisingly, CD117 expression decreases on PB and BM CD34 + CD38 − cells while it remains stable in CB. The regulation of CD117 expression after short-term incubation with SCF + IL-3 seems very heterogeneous according to the type of samples and the subpopulation evaluated. Nevertheless, it could be noted that, after 48 h culture, CD117 expression
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+ cells C De Bruyn et al 381 Table 3 CD117 expression on CD34 on PB progenitor cells is significantly lower than on their CB and BM counterparts (respectively P Ͻ 0.006, Ͻ0.0002, Ͻ0.004 and P Ͻ 0.01, Ͻ0.01, Ͻ0.01 for the CD34 + , CD34 + CD38 + and CD34 + CD38 − cells). When we compared the percentage of CD117 positive cells, the same differences between PB vs CB and BM progenitor cells, although less spectacular, are also observed. At day 0 as after 48 h, we did not observe a significant difference between CD117 expression on CB and BM cells.
CD123 expression on CD34
+ subpopulations from CB, BM and mobilized PB at day 0 and after 48 h culture (Figure 2) (Table 4) CD123 expression is not significantly different in the three sources of hematopoietic cells. After 48 h of culture the density of IL-3 receptors increases in all subpopulations while the percentages of positive cells remain constant. We did not observe significant differences between the three tissues.
Discussion
Mobilized peripheral blood (PB) and umbilical cord blood cells (CB) are two alternative sources of allogeneic stem cells to bone marrow (BM) for transplantation. 1 There are increasing reports demonstrating differences in phenotype and functional properties between hematopoietic progenitors from PB, CB and BM. 5, 10, [14] [15] [16] The most striking difference between BM, PB and CB is in the hematopoietic Table 4 CD123 expression on CD34 
CD38
− cells and are calculated using the Student's paired t-test. b P represents significant difference between CD123 expression at day 0 and after 48 h culture in the three subpopulations and are calculated using the Student's paired t-test.
Bone Marrow Transplantation recovery following transplantation which is faster after PB and delayed after CB transplantation when compared to BM.
1,2 The difference of engraftment kinetics between the three sources of progenitor cells are not yet fully understood. The impact of cell dose is probably important but remains controversial. 17 On the other hand, it seems reasonable to hypothesize that qualitative difference between CD34 + populations of the three sources could also play a role in engraftment kinetics. Comparative studies of the CD34 + subpopulations in the three sources of stem cells may contribute to understanding the mechanisms involved in hematologic recovery after transplantation.
In this study, we have first identified the cell cycle status of CD34 + CD38 − and CD34 + CD38 + subpopulations in steady state BM, PB and CB samples. In accordance with previous studies, [18] [19] [20] [21] [22] it appears that the great majority of CD34 + cells from CB and particularly PB, are in G0/G1 phases of the cell cycle whereas more than 10% of the BM CD34 + cells are in S + G2M phases. We have also observed this difference between on the one hand, CB and PB and on the other hand, BM, for the immature CD34 + CD38
− fraction (Ͻ2% in S+G2M for PB and CB and Ͼ5% for BM). Short-term incubation of these cells with SCF + IL-3 allows a significant increase in the percentage of cycling CD34 + CD38 − cells in CB and PB while the proliferative potential of BM CD34 + CD38 − cells is not significantly modified. It seems thus possible to trigger during a shortterm culture, the cycling status of PB and CB progenitor cells without radically modifying their number or their phenotype. Taking into account this particular aspect, it appears that the CB CD34
+ progenitors seem to have more similarities with PB than with BM CD34 + cells. These surprising results cannot explain the different behavior between CB and PB cells after transplant. Therefore, cell cycle differences are unlikely to explain the marked difference in post-transplant recovery between PB and CB.
Our results, demonstrating that PB CD34 + cells and particularly CD34
+ CD38 − cells respond rapidly to SCF + IL-3, seem to confirm the observation of Lemoli et al 23 which have shown that the majority of mobilized peripheral blood CD34 + cells, including LTC-IC, are not quiescent (G0 phase), but are in G1 phase of the cell cycle and are thus ready to progress into S-phase under CSF stimulation. The ability of CB and PB immature progenitors to exit G0/G1 phases more rapidly than their BM counterpart could derive from a difference in receptor expression for the two cytokines used (SCF and IL-3). We have thus investigated the expression of SCF and IL-3 receptors on the different CD34 + subpopulations and the short term in vitro modulation of this expression by cytokines.
It is well documented that the SCF/c-kit interaction pays a crucial role in the early stage of hematopoiesis. However, conflicting reports have described c-kit expression [24] [25] [26] and little is known concerning the modulation of this expression on the immature and more committed progenitor cells. Therefore, it will be important to elucidate c-kit expression on different subpopulations of progenitors. Our results, in accord with those from several others groups, The low expression of c-kit on PB cells that we have observed in this study was previously related to the mobilization of CD34 + cells into the circulation after G-CSF administration. 29, 30 This observation gives a new importance to c-kit expression in mobilization and in adhesion of hematopoietic stem cells to bone marrow microenvironment. In fact, it is well known that c-kit is not only a cytokine receptor but also an adhesion molecule. 31, 32 The SCF/c-kit complex was previously shown to play an important role in the homing of hematopoietic stem cells to the bone marrow microenvironment. 33 As we postulated that the hematopoietic recovery after transplantation is dependent in vivo to homing of cells to bone marrow stromal cells and to proliferation of hematopoietic stem cells in this microenvironement, we can suppose that in vitro down-regulation of the CD117 expression, as observed for the PB immature progenitors cells, may impaired engraftment. This hypothesis is confirmed by data from Gothot et al 34 who showed that 36 h stimulation by cytokines activates cell cycle and decreased the ability of human PB cells to repopulate SCID/NOD mice and from Szilvassy et al 35 who recently observed the same decline in the homing capacity of murine progenitors after ex vivo culture.
In the same way, several authors have described that transplantations with ex vivo expanded CD34
+ cells do not permit reconstitution of stable long-term hematopoiesis, 36, 37 indicating loss of repopulating capacities of immature progenitor cells during ex vivo culture. These observations, although controversial, 38 suggest that functional modifications could occur during the ex vivo manipulation and have an impact on the engraftment capacities of stem cells.
In conclusion, these experiments provide evidence that short term ex vivo culture can modify stem cells at different levels (their cell cycle status and the expression of adhesion molecules) and can influence the engraftment capacity of these cells. Moreover these modifications are very heterogeneous depending on the source of stem cells and the subpopulations studied. On the other hand, the in vitro proliferative, as well as adhesive, capacities of progenitor cells, although very important, do not seem to be the only limiting factors for the in vivo cell engraftment. Further studies will be needed to elucidate the relationship between cell behavior, cell cycle changes, expression of adhesion molecules, cytokine receptor expression and the capacity of cells to adhere to the bone marrow microenvironment. 
